{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-103994","form_type":"8-K","ticker":"SERA","cik":"0001534969","company_name":"SERA PROGNOSTICS, INC.","filed_at":"2025-08-06T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.265736+00:00","generated_at":"2026-05-17T19:24:42.536613+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Sera Prognostics Q2 revenue $17K, net loss $8.0M, PreTRM progress","bullets":["Revenue $17,000 vs $24,000 in Q2 2024; net loss $8.0M vs $8.3M.","Operating expenses $9.3M flat; R&D down 24% to $3.3M; SG&A up to $6.0M.","Cash $108.5M as of June 30, 2025, expected to fund through 2028.","PRIME study full results on track for publication this year; commercial traction with Medicaid plans.","Appointed Lee Anderson as CCO, Chuck Hyde as Head of Market Access, Jennifer Zibuda as Head of IR."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-103994","json":"https://secwatch.observer/filing/0000950170-25-103994.json","markdown":"https://secwatch.observer/filing/0000950170-25-103994.md","text":"https://secwatch.observer/filing/0000950170-25-103994.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1534969/000095017025103994/0000950170-25-103994-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1534969/000095017025103994/sera-20250806.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T19:24:42.536613+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}